Patent · US Active

Truncated BAFF receptors

US8022182B2 · kind B2 · utility

1Cited by

12References

3Claims

0Family size

Assignee

BIOGEN IDEC MA INC. · US

Inventors

Christine Ambrose · Reading, US
Jeffrey Thompson · Hightstown, US
Yen-Ming Hsu · Lexington, US
Dingyi Wen · Waltham, US
Yaping Sun · Lexington, US

Key dates

Filing date	Feb 11, 2010
Grant date	Sep 20, 2011
Priority date	—
Expiry date	Feb 11, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides a non-naturally occurring BAFF-R glycoprotein having a deletion in the extracellular domain which results in an altered O-linked glycosylation pattern. The disclosure also provides methods and pharmaceutical compositions for treating B-cell- and T-cell-mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.